Wednesday, June 19, 2019 4:32:35 PM
This is how KERN got listed on NASDAQ. All I can say about their strategy is "well done."
"Stock of MJ Freeway parent Akerna rose nearly 30% in Tuesday trading after debut on small-cap market
To accomplish the feat of becoming the first cannabis-software stock to list on the Nasdaq, MJ Freeway Chief Executive Jessica Billingsley employed a strategy well known to Wall Street veterans.
Rather than attempt to go through the expensive and time-consuming process of an initial public offering -- the route chosen by vape supplier Greenlane Holdings Inc (http://www.marketwatch.com/story/greenlane-ipo-5-things-to-know-about-the-closest-thing-to-a-us-cannabis-company-to-go-public-on-nasdaq-2019-04-12).(GNLN) and Canadian weed producer Tilray Inc (http://www.marketwatch.com/story/tilray-ipo-five-things-to-know-about-the-first-pot-company-to-go-public-on-nasdaq-2018-07-10).(TLRY) -- Billingsley opted to merge MJ Feeway with a special purpose acquisition company by the name of MTech Acquisition.
The resulting entity, called Akerna Corp.(KERN), began trading Tuesday, and closed up 28% at $15.35. By Tuesday's close, the company's market value was $71.9 million after 144,897 shares changed hands, according to FactSet.
Canadian marijuana companies can cross-list their stock on senior U.S. exchanges by virtue of the fact that cannabis is allowed under federal law in Canada, and many have opted to do so (http://www.marketwatch.com/story/another-canadian-pot-stock-is-headed-for-a-us-exchange-2019-04-29). U.S. companies have no such luck -- Nasdaq and the New York Stock Exchange have banned companies that violate U.S. federal law, excluding most of the pot companies in the U.S. and forcing them on to the Canadian Securities Exchange (http://www.marketwatch.com/story/in-the-wild-west-of-pot-stocks-us-companies-create-a-green-rush-2018-12-14).
What's less clear -- because the senior exchanges refuse to talk about it publicly -- is what happens to companies that service the cannabis industry but don't actually break federal law. These companies, which "don't touch the plant" in colloquial terms, seem to be breaking through on a case-by-case basis, with Akerna following Greenlane onto Nasdaq's junior exchange..."
Written by:
Max A. Cherney
AskNewswires@dowjones.com
(END) Dow Jones Newswires
June 19, 2019 14:33 ET (18:33 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
"Stock of MJ Freeway parent Akerna rose nearly 30% in Tuesday trading after debut on small-cap market
To accomplish the feat of becoming the first cannabis-software stock to list on the Nasdaq, MJ Freeway Chief Executive Jessica Billingsley employed a strategy well known to Wall Street veterans.
Rather than attempt to go through the expensive and time-consuming process of an initial public offering -- the route chosen by vape supplier Greenlane Holdings Inc (http://www.marketwatch.com/story/greenlane-ipo-5-things-to-know-about-the-closest-thing-to-a-us-cannabis-company-to-go-public-on-nasdaq-2019-04-12).(GNLN) and Canadian weed producer Tilray Inc (http://www.marketwatch.com/story/tilray-ipo-five-things-to-know-about-the-first-pot-company-to-go-public-on-nasdaq-2018-07-10).(TLRY) -- Billingsley opted to merge MJ Feeway with a special purpose acquisition company by the name of MTech Acquisition.
The resulting entity, called Akerna Corp.(KERN), began trading Tuesday, and closed up 28% at $15.35. By Tuesday's close, the company's market value was $71.9 million after 144,897 shares changed hands, according to FactSet.
Canadian marijuana companies can cross-list their stock on senior U.S. exchanges by virtue of the fact that cannabis is allowed under federal law in Canada, and many have opted to do so (http://www.marketwatch.com/story/another-canadian-pot-stock-is-headed-for-a-us-exchange-2019-04-29). U.S. companies have no such luck -- Nasdaq and the New York Stock Exchange have banned companies that violate U.S. federal law, excluding most of the pot companies in the U.S. and forcing them on to the Canadian Securities Exchange (http://www.marketwatch.com/story/in-the-wild-west-of-pot-stocks-us-companies-create-a-green-rush-2018-12-14).
What's less clear -- because the senior exchanges refuse to talk about it publicly -- is what happens to companies that service the cannabis industry but don't actually break federal law. These companies, which "don't touch the plant" in colloquial terms, seem to be breaking through on a case-by-case basis, with Akerna following Greenlane onto Nasdaq's junior exchange..."
Written by:
Max A. Cherney
AskNewswires@dowjones.com
(END) Dow Jones Newswires
June 19, 2019 14:33 ET (18:33 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2025 09:25:41 PM
